Govt Approves Sinovac Jabs 'in The Public Interest'
"); jQuery("#212 h3").html("
"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1576185_1_20210218193250.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1576185-20210218.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1576185-20210218.htm', 'DCS.dcsqry', '' ); } } }); }); });
2021-02-18 HKT 12:16
Share this story
The government on Thursday approved the use of a Covid-19 vaccine made by mainland firm Sinovac, describing it as a necessary move and one that is in the public interest.
Experts advising the SAR authorities on coronavirus vaccines said earlier this week that with a reported efficacy rate of 62.3 percent, the protection offered by the Sinovac jabs would outweigh any risks.
A million doses of the vaccine are expected to arrive in Hong Kong on Friday, with doctors anticipating that the vaccination programme could be rolled out as soon as next week.
A government statement said the secretary for health considered it necessary to approve the Sinovac jabs after considering the experts' opinion and the public health risks posed by the pandemic.
The statement said the government will complete the necessary quality checks after receiving the jabs, and will continue to ask Sinovac to provide it with the latest clinical data.
The SAR government eventually decided not to require the mainland company to publish clinical data in medical journals before its jabs could be approved here. The vaccine has so far not been approved by the World Health Organisation.
The Sinovac vaccine is the second approved for use in the SAR, after jabs made by German firm BioNTech were earlier given the green light.
Ant International And Bank Of China Partner To Enhance Cross-Border Payment Connectivity
Ant International and Bank of China (Hong Kong) (“BOCHK”) announced a partnership which leverages BOCHK’s banking... Read more
BitGo Korea Gets Green Light For Virtual Asset Custody, Backed By SK Telecom
BitGo Holdings, Inc. (BitGo) announced that its subsidiary, BitGo Korea, Inc. (BitGo Korea), received its Virtual Asset... Read more
Webinar: When Account Takeover Moves Past Onboarding
Account takeover shows why fraud risk cannot be treated as an onboarding problem. Fraudsters are using stolen credentia... Read more
JCB To Trial Stablecoin Payments In Japan With Digital Garage And Lawson
JCB Co., Ltd. (JCB), Digital Garage, Inc. (Digital Garage), and Lawson, Inc. (Lawson) announced that they have jointly ... Read more
Bonnie Chan To Lead HKEX Until Feb 2030 After Securing Second Term
The HKEX Board of Directors has approved the renewal of the employment contract of Hong Kong Exchanges and Clearing Lim... Read more
Ripple Signs Its First Korean Regional Bank In Cross-Border Remittance Deal
Ripple, a blockchain-based enterprise solutions provider for traditional and digital finance, announced a partnership w... Read more